Answers are grounded in this paper and cite their sources.
Invasive fungal in fections (IFIs) are amongst the most important causes of morbid ity and mortality in immunocomp ro mised patients. To more effectively approach IFIs both in prophylactic and therapeutic perspectives, one of the crucial imperatives is to know about the local fungal epidemiology. This is relatively lacking in our current setting. Insufficient diagnostic tools as well as the progressive and life-threatening course of IFIs when consolidated, compro mise the IFI t reatment outcome in many cases. This necessitates primary antifungal prophylactic approaches in immunocompro mised hosts who are mainly at risk. To stay aligned with regard to IFI prophylactic strategies in our practice and to pave the path towards definition of local guidelines, the Shiraz IFI Study Group held a consensus meeting on 6 th December 2012, in Namazi hospital, Shiraz, Iran. Experts fro m hemato-oncology and infectious disease fields reviewed the available evidence-based data with regard to prophylactic strategies against IFIs so that to draw the preliminary agreed-upon algorith mic approach.
No takes yet. Share an insight, caveat, or question.
Moghadami et al. (2013) studied this question.
Synapse has enriched one related paper. Consider it for comparative context: